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Abstract
Conventional radiotherapy has shown its efficiency since decades with large progresses 
during the 1990s. However, for 15–20% of treated patients, there is no prognosis improve-
ment either due to tumor radiation resistance and/or to side effects on normal tissues 
representing the limiting dose given during a radiotherapy protocol. A new modality 
of radiation therapy has emerged representing a technological breakthrough: hadron-
therapy. This regroups mainly proton and carbon ion therapy. Dose deposit is in favor 
of hadrons compared to photons as it occurs at a precise depth in human body sparing 
upstream and downstream normal tissues. Mechanisms of action of photons and had-
rons are different. When photons mainly act by water radiolysis—producing e−
aq
, H●, 
●OH, H2O2, O2●−…, carbon ions and protons mainly act by direct effects, i.e. by direct transfer of ion energy to biological macromolecules. Moreover, efficiency of carbon 
ions is considered threefold higher (1.1 for protons) than X-rays in killing tumor cells, 
whereas it is considered lower for normal cells. These findings suggest strong advantages 
of hadrontherapy compared to conventional radiotherapy. However, some recent studies 
tend to show a stronger increase in oxidative stress in normal cells after protons or carbon 
ions than X-rays.
Keywords: hadrontherapy, oxidative stress, carbon ions, protons, DNA damage,  
tumor killing efficiency, normal tissue toxicity, senescence, inflammation
1. Introduction
Oxidative stress is of major interest in killing tumor cells. In this way, radiation therapy is one 
of the most used modality for cancer treatment (Figure 1). Ionizing radiations lead to the pro-
duction of deleterious reactive oxygen species that overcome antioxidant systems resulting in 
tumor cell death. On the 14 million of new cancer cases each year in the world, about half of 
them will benefit from this treatment [1].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the t rms of the Crea ive
Comm ns Attribution Lic nse (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Conventional radiotherapy—by photons (γ- or X-rays)—has known a revolution since the 
1990s, mainly thanks to progresses in imagery, computer sciences and robotics. In this way, 
new modalities of radiation therapy occurred: intensity-modulated radiotherapy (IMXRT), 
image-guided radiation therapy (IGRT) and respiratory-gated radiotherapy: the 4D radio-
therapy. These new kinds of treatments allowed to overcome the main difficulties encoun-
tered in conventional radiotherapy: the exponential dose deposit which leads to an overdose 
in normal tissues upstream and downstream from the tumor (Figure 2, left panel) [2].
In parallel, therapy by accelerated hadrons was developed since the 1950s (Berkeley, United 
States). Hadronic particles regroup neutrons, protons, pions, antiprotons, helium, lithium, 
boron, carbon and oxygen ions. The major interest of protons and heavy ions (mass greater 
than helium) lies in the profile of dose deposit: the Bragg peak (Figure 2, right panel). Contrary 
to conventional radiations, dose distribution is in favor of normal surrounding tissues as the 
maximum of dose is deposited at a precise depth in the matter with a larger peak for protons 
than for carbon ions. However, a plateau phase does exist upstream from the peak, resulting 
in a small proportion of dose deposition in normal tissues preceding the tumor, as well as a 
fragmentation tail downstream from the peak (except for protons which cannot fragment in 
smaller particles). Moreover, in the case of heavy ions, their fragmentation when encounter-
ing matter lead to secondary particles, which properties are different in terms of LET (linear 
transfer energy) and biological effects. In addition, to treat the whole tumor volume, hadron 
beam energy and direction are modified to spread the peak: SOBP, Spread Out Bragg Peak 
(Figure 2, right panel). This leads to an addition of plateau phases as well as fragmentation 
Figure 1. Cancer treatment: focus on radiotherapy.
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tails. In this way, normal surrounding tissues received a percentage of dose that could be non-
negligible according to the tumor size and localization.
Radiations lead to a wide range of oxidative damage to DNA, lipids and proteins. Effects of 
photons were widely studied in vitro and in vivo since decades. When photons mainly act 
by indirect effects, i.e. water radiolysis—producing e−
aq
, H●, ●OH, H2, H2O2, H+, OH−, O2●−…, carbon ions and protons mainly act by direct effects, i.e. by direct transfer of ion energy to 
biological macromolecules.
We propose to develop involvements of oxidative stress in: (i) tumor cell killing efficiency of 
hadrontherapy and (ii) side effects of hadrontherapy—secondary tumors and normal tissue 
injury.
2. Oxidative stress and tumor cell killing efficiency of hadrontherapy
The main advantages of the use of hadrons in comparison with photons are their superior 
dose localization, their efficiency against radioresistant and hypoxic tumors and the ability to 
shorten treatment planning.
2.1. Interest of protons and carbon ions in clinics
Due to their high charge, heavy ions lead to concentrate ionizations when they cross matter. 
These concentrate ionizations result in concentrate oxidative damage. On the contrary, when 
photons (low LET) encounter matter, they produce low ionization densities. Tumor cell kill-
ing is more efficient with hadrons as, for example, clusters of DNA damage are produced 
leading to difficult DNA repair in comparison with photons producing more easily repaired 
SSB (single-strand breaks). Efficiency—RBE for Relative Biological Efficiency—of carbon ions 
Figure 2. Dose deposit after X-rays in comparison to hadrons. Left panel: Dose deposit of X-rays according to depth in 
human body. Right panel: Dose deposit of hadrons according to depth in human body. Bragg peak: Continuous black 
line. SOBP: Dotted line.
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is considered twofold to threefold higher (1.1 for protons) than X-rays in killing tumor cells. 
These RBE are calculated for a percentage of clonogenic survival of 10%. However, experi-
ments leading to these values were performed under a broad range of conditions, among 
other things: LET or cell cycle phase—cell irradiation at confluence stage or during expo-
nential phase. In this way, higher RBE than 3 were found—up to 5, for example, 3.3 for nor-
mal human skin fibroblasts exposed at confluence stage to mimic skin physiology to carbon 
ions in the plateau phase before Bragg peak as it would be the case during radiotherapy [3]. 
Biological interactions of protons and carbon ions being a lot more complex than photons, 
and to improve hadrontherapy, there is a need of a better knowledge of biological effects, at 
early and late times, of hadrons according to LET, fractionation, cell type, oxygenation, cell 
cycle phase, etc. (for review [4]). Due to the favorable dose deposit profile, this kind of therapy 
is recommended for unresectable and radioresistant tumors. Until now, more than 110,000 
patients have been treated by proton therapy and 15,000 patients by carbon ion therapy.
Concerning protons, numbers of pediatric tumors were treated by protons as the dose deposit 
should be favorable for normal surrounding tissues: medulloblastoma [5, 6], rhabdomyosar-
coma [7, 8], craniopharyngioma [9], etc. There is a trend to extend the indications for proton 
therapy from already treated skull base [10, 11] and brain [12–14] tumors to prostate [15–17], 
lung [18–20], head and neck (for review, [21]), gastrointestinal (for review, [22]) and breast 
[23] cancers. Compared to conventional radiotherapy, proton therapy obtained the same 
results in terms of tumor local control (for review, [24]). The superiority of protons is still 
discussed, except in large ocular melanomas, chordomas and chondrosarcomas [25].
The main experienced facilities providing carbon ion beams and treating a big number of 
patients are: NIRS (Japan) and GSI and then HIT (Germany). The main indications were, as 
for protons, not only pediatric cancers but also bone and soft tissue sarcomas; head and neck 
cancers; pancreas, prostate and cervix cancers; hepatocellular carcinomas and glioblastoma 
(for review, [26–28]). Carbon ion therapy present significant advantages, but, due to a lack of 
available data in the literature, clinical evidences are still lacking.
2.2. DNA damage and repair, mitotic catastrophe
Hadrons are considered as acting mainly by direct effects. Carbon ions are particularly delete-
rious in terms of cell survival, viability and apoptosis, even on very radioresistant tumor cell 
lines [29, 30]. This efficiency to kill tumor cells could come from the type of damage produced 
by carbon ions: DSB (double-strand breaks) and clustered DNA damage considered as dif-
ficult to repair. Clusters of damage could be a criterion explaining ion irradiation efficiency as 
it was shown that cluster number increases with LET. However, Hada et al. [31] have shown 
that DNA damage (DSB, abasic sites, oxidized bases) number decreased in genomic DNA 
irradiated at high LET and DSB was more frequent than other damage after charged particles, 
even low-LET protons, than after X-rays. In the same manner, Heilmann et al. [32] demon-
strated that carbon ion irradiation (LET from 14 to 400 keV/μm) did not generate more DSB 
than X-rays (kV) with a maximum of about 38 DSB/Gy/cell. A possible explanation for the 
strong RBE of carbon ions could be related to DNA damage repair. Moertel et al. [29] showed 
that residual DSB were more numerous in ion-irradiated human glioblastoma cells than in 
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X-ray-irradiated cells. Moreover, Weyrather et al. [33] highlighted that carbon ion RBE was 
related to cell repair capacity. The role of HR (homologous recombination) was highlighted 
after proton irradiation as deficiency in this pathway leads to a sensitization of cells to protons 
[34]. DNA repair by the Ku-dependent NHEJ (non-homologous end joining) pathway was 
shown as inhibited by high-LET irradiation [35]: the yield of DSB should be the same after 
low- or high-LET irradiation but high-LET induced smaller fragments inhibiting the efficient 
binding of Ku to DSB fragment. However, there are reports of a primordial role of NHEJ after 
carbon ions as inhibition of DNA-PKcs led to a sensitization of cancer cells to carbon ions 
[36]. Recent report pointed out another response to DNA damage after carbon ion irradiation: 
mitotic catastrophe. Kobayashi et al. [37] demonstrated that mitotic catastrophe phenomenon 
was induced in a larger manner after carbon ions than after X-rays in 20 human cancer cell 
lines, whereas apoptosis and senescence were unchanged between both radiation types.
2.3. Oxygen effect and carbon ions
Hypoxic tumor cells are reoxygenated during radiotherapy treatment, and this reoxygenation 
plays an important role on treatment efficacy [38]. Hypoxic tumors resist to X-rays, whereas 
carbon ion exposure remains efficient [39]. The same study showed that this could come from 
a faster reoxygenation of tumors after carbon ion irradiation compared to X-rays. This was 
confirmed by Oya et al. [40] and also by Fukawa et al. [41] by pO2 measurements in mouse 
fibrosarcomas. Recently, Wozny et al. [42] have shown that hypoxia-induced factor HIF-1α, 
whose role was demonstrated in radioresistance to conventional radiotherapy, is expressed 
earlier in carbon irradiated cancer stem cells—subpopulation of head and neck squamous 
cell carcinoma—localized in tumor hypoxic areas. In the presence of oxygen, ROS quantity 
increases leading possibly to a major oxidative stress and so to a stronger attack of biological 
macromolecules. Oxygen effect could play a major role in the difference observed between 
carbon ion and photon responses as hypoxia leads to a decrease in DSB repair capacity [43]. 
Hirayama et al. [44] observed a decrease in DNA damage after hypoxia but this was much less 
significant after carbon ion than after X-ray irradiation. Moreover, the same study demon-
strated that repaired DSB percentage was unchanged after carbon ion irradiation in hypoxic 
conditions, which is not the case for X-rays. The authors concluded that DSB repair plays an 
important role in oxygen effect as this effect was decreased after carbon ion irradiation com-
pared to X-rays. This could be related to a stable effect of oxygen on DSB during the time after 
carbon ion irradiation, whereas it decreases after X-ray irradiation.
2.4. Role of oxidative stress in hadrontherapy efficiency
Studies are controversial concerning protons. The use of edaravone, a radical scavenger, did 
not decrease DNA DSB formation in MOLT-4 tumor cells after protons as it was the case for 
X-rays leading to conclude that radical-induced indirect DNA damage was lower with pro-
tons than with X-rays [45]. However, Baran et al. [46] showed that proton irradiation led to 
a disruption of the electron flow in the complex I of the mitochondrial respiratory chain in 
human leukemia Jurkat T cell, and the use of antioxidants in HeLa cancer cell line allowed an 
attenuation of the enhancement of radiation-activated gene expression [47].
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Concerning carbon ions, studies performed at high radiation doses (30 Gy) on murine squa-
mous cell carcinoma and fibrosarcoma transplanted in mouse allowed to provide evidence 
of a strong upregulation of stress-responsive and cell communication genes after carbon ion 
irradiation compared to γ-rays [48]. Moreover, glutathione depletion in human squamous 
cell carcinoma cell lines potentiates the effects of carbon ion irradiation [49]. In this way, 
heavy ions do not act only by direct interaction with biological macromolecules but also by 
an induction of oxidative phenomena.
3. Oxidative stress and side effects of hadrontherapy
Radiotherapy aims to destroy cancer cells by the use of photons, protons or heavy ions. But 
this is a double-edged sword as it can also kill normal cells. Two types of side effects can 
appear: deterministic (pneumonitis, gastrointestinal or cutaneous syndrome, etc.) or stochas-
tic (carcinogenesis and genetic effects). Indeed, dose deposit is exponential for photons so that 
the maximum of the dose is given at the entrance in the body before reaching tumor. In this 
way, normal tissues—present upstream and downstream from the tumor—receive ionizing 
radiations leading to ROS (reactive oxygen species) production. When normal cells are unable 
to detoxify these ROS, there is an imbalance leading to oxidative stress. Signaling pathways 
leading to inflammation maintain this process, therefore participating to side effects on nor-
mal tissues. It is considered that 5–10% of the general population exhibit acute or late adverse 
effects after radiotherapy. For example, pneumonitis is observed in 5–15% of patients irradi-
ated for breast, lung and mediastinal tumors [50]. By the use of hadrons, organs at risk present 
around the tumor could be spared, and biological efficiency is considered higher in tumors 
than in normal tissues. In this way, treatment time could be shortened by hypofractionation 
of the total radiotherapy dose: 3 weeks compared to 6–7 weeks.
3.1. Toxicity encountered in patients after proton or carbon ion therapy
Toxicities of radiation therapy can not only occur at skin level (dermatitis, telangiectasia, etc.), 
cardiovascular and pulmonary level (pneumonitis, cardiovascular disease, etc.), gastrointes-
tinal level (xerostomia, mucositis, esophagitis, enteritis, proctitis, emesis) and genitourinary 
level (cystitis, erectile dysfunction, vaginal dryness and stenosis, infertility and teratogenic-
ity), but also at psychological level with fatigue and depression (for review [51]).
Proton therapy studies reported approximately the same proportion of early toxicities than 
photon therapy. However, comparative studies to photons are still necessary when possible. 
Recent reports tend to show a decrease in early and late toxicity: Romessser et al. [52] reported 
that proton therapy for head and neck cancers had significantly lower rates of early grade 
2 (grade represents the degree of gravity of toxicity) or greater acute dysgeusia (5.6 vs. 65.2%), 
mucositis (16.7 vs. 52.2%) and nausea (11.1 vs. 56.5%). Yock et al. [53] reported ototoxicity and 
neuroendocrine deficit, but no cardiac, pulmonary or gastrointestinal late effects after treat-
ment of medulloblastomas by protons, with a median follow-up of 7 years.
First studies of patients undergoing carbon ion therapy and presenting side effects were 
reported during the end of the 2000s (for review, [26]). Comparative studies on toxicities 
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of carbon ion therapy versus conventional radiotherapy are still missing. Concerning bone 
and soft tissue sarcomas, toxicities were mostly decreased compared to conventional radio-
therapy. A report showed that, on 78 patients treated by carbon ion therapy for unresect-
able osteosarcomas, grade 3 acute and late skin reactions were seen in 3 and 4 patients, 
respectively, and grade 4 skin and soft tissue reaction occurred in 3 patients [54]. However, 
for an escalation dose protocol, toxicities were considerably increased: 34 on 35 patients 
present acute skin reactions and 26 on 27 patients late skin reactions up to grade 4 [55]. 
For unresectable sarcomas: on 47 patients treated for non-sacral spinal sarcomas, 1 patient 
presented grades 3 and 4 late skin reaction and 1 patient grade 3 spinal cord reaction [56]; 
6 patients and 2 patients on 188 patients with sacral chordomas presented grade 3 peripheral 
nerve and grade 4 skin toxicity, respectively [57]; and 4 patients on 75 patients treated for 
non-skull base chondrosarcomas report grade 3 or 4 late skin and soft tissue reactions [58]. 
Except bone and soft tissue sarcomas, most of toxicity was encountered for cervical cancers: 
a dose escalation protocol led to 18% of major gastrointestinal toxicity [59], and in another 
study, 8 patients on 29 developed bladder complications and 4 patients presented grade 
4 rectal toxicities [60]. Clinical trials are in progress to register toxicities in the different facili-
ties providing carbon ion therapy [26].
Induction of secondary tumors was also reported. Concerning protons, Chung et al. [61] stud-
ied 558 patients treated by protons and 558 treated by photons: second malignancies occurred 
in 5.2% of proton patients compared to 7.5% of photons. They concluded that proton therapy 
was not associated with a significantly increased risk of secondary malignancies compared 
with photon therapy, but the follow-up of these patients was only around 6 years after radia-
tion therapy. This reduced risk of secondary malignancies due to proton therapy was con-
firmed by Sethi et al. [62], whereas there are no enough long-term reports after carbon therapy. 
Indeed, concerning carbon ions, literature on secondary tumors is still poor but a study pointed 
out that 30% of patients treated for cervical cancers developed distant metastases [63]; a case 
was reported of a brain tumor induced by heavy particle radiotherapy [64]. Preclinical stud-
ies, recently performed on mice exposed to carbon ions in comparison to photons, revealed 
that interstitial chromosome deletions were more increased in secondary cancers induced by 
carbon exposure [65]. They contradict previous results of Ando et al. [66] showing the same 
induction in carbon locally irradiated mice of secondary tumors after γ-rays.
3.2. DNA damage and repair, mitotic catastrophe
Production of clusters of DNA damage can lead to mitotic catastrophe in fast or slow renewal 
normal tissues then leading to early or late toxicities. A lower immediate increase in DNA 
damage measured by alkaline comet assay was observed in confluent primary cultures of 
skin fibroblasts after carbon ion versus X-ray irradiation but a late increase in DNA dam-
age was observed only after carbon ions whereas it was not the case after X-rays [3]. The 
lower immediate increase could be explained by the production of smaller fragments after 
carbon ions compared to X-rays whereas the late production of DNA damage after carbon 
ions could come from DNA repair. Indeed, micronucleus frequency—described as a result of 
impaired repair of DNA double-strand breaks—was 1.7-fold increased 24 hours after carbon 
irradiation compared to X-rays (unpublished results) and this increase persisted 2 weeks after 
irradiation (unpublished results) where a late wave of oxidative damage was observed [3]. 
Oxidative Stress in Hadrontherapy
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Results obtained by Antonelli et al. [67] on quantification of γ-H2AX foci after carbon ion vs. 
X-ray irradiation in lung fibroblasts showed a longer persistence of γ-H2AX foci after carbon 
ion irradiation which is in agreement with a more difficult repair of DNA complex damage. 
Moreover, Gustafsson et al. [68] studied, in normal human skin fibroblasts, clustered DSB 
and non-DSB lesions which convert into DSB during preparation for pulsed-field gel elec-
trophoresis and their results showed a similar increase after carbon ion or low-LET irradia-
tion. It was recently shown that clustered DSB perturb normal human fibroblast DNA repair 
after high LET irradiation [69]. In confluent normal fibroblasts, accumulations of p53 at early 
times and p21 at late times were 2–3 times higher after carbon ions than after X-rays [70]. 
DNA repair proteins (hMRE11, p21, PCNA) were accumulated along ion trajectory in normal 
human fibroblasts and this was dependent of chromatin compaction [71].
3.3. Role of oxidative stress in hadrontherapy toxicity
Highest toxicity of carbon ions, and in a lower extent of protons, could come from indirect 
effects of irradiation, i.e. due to a stronger concentration of reactive oxygen and nitrogen spe-
cies that cells would not be able to detoxify. However, only few studies were interested in 
oxidative phenomena occurring after carbon ion or proton irradiation.
Wan et al. [72] showed that ROS production in human epithelial cells occurred in the same 
proportion after proton or X-ray irradiation. Whole body proton irradiation of mice also led 
to an early differential modulation of oxidative stress gene expression in liver: only proton 
irradiation led to an increase in Prdx6 and Sod3, mainly, whereas other genes were common 
to photon irradiation [73]. Chang et al. [74] demonstrated that whole body proton irradiation 
of C57BL/6 J mice leads to a late increase in ROS production, NOX4 transcription and DNA 
damage in hematopoietic stem cells from irradiated mice. Proton irradiation of rat eye led to 
an upregulation of oxidative stress and apoptosis gene expression [75]. Baluchamy et al. [76] 
concluded that, after proton irradiation, mouse brain presented modifications in expression 
of genes related to oxidative stress which could lead to programmed cell death. Moreover, 
the use of antioxidants allowed to protect against biological effects of protons not only in 
vitro [77] but also in vivo [78], which tends to demonstrate the importance of oxidative stress. 
Transgenic mice overexpressing human mitochondrial catalase presented protective effects 
on low-dose proton-induced brain injury [79]. In the same manner, neuroprotective effects of 
reducing mitochondrial ROS were also shown by Liao et al. [80] in proton irradiated mice not 
only at low dose but also at a higher dose of 2 Gy. SOD mimetic was also shown efficient in 
reducing oxidative damage in retinal cells from proton eye-irradiated rats [81] and in amelio-
rating acute and chronic proctitis in focal proton irradiated rat rectum [82].
After carbon ion irradiation, an increase in oxidative stress was observed in confluent irradi-
ated primary cultures of normal human skin fibroblasts with an increase in biological macro-
molecule damage and a decrease in antioxidant enzyme activities in comparison with X-rays 
[3, 83]. This trend was confirmed by Dettmering et al. [84]: an increase in superoxide anion 
production was measured in normal human fibroblasts and the maximum level was obtained 
at a lower dose after carbon irradiation than after X-rays. In human hematopoietic stem/
progenitor cells (HSPCs), carbon irradiation led to a strong increase in heme oxygenase-1 
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and NAD(P)H dehydrogenase-quinone 1 expression [85]. In vivo, mouse whole-body carbon 
irradiation was shown to decrease glutathione level and to increase MDA content in testis 
one week after irradiation [86]. At longer term - 2 months after exposure - and in comparison 
to gamma-rays, mouse whole body irradiation led, in intestine and colon, to: (i) a persistent 
increase in ROS, mitochondrial cardiolipin oxidation and lipid damage; (ii) a late decrease 
in antioxidant enzyme activities [87]. The use of other antioxidants indirectly pointed out 
an important role of oxidative phenomena. Indeed, some antioxidants allowed to decrease 
effects of carbon ions in normal cells or tissues: curcumin ameliorates cognitive deficits in car-
bon-irradiated mice via SOD increase, MDA decrease and upregulation of important genes 
in oxidative stress pathways like heme oxygenase-1 and NAD(P)H quinine oxidoreductase 1 
[88]; melatonin reduced carbon-induced apoptosis in mouse carbon-irradiated testes [89] and 
brain [90] via a decrease in carbonyl and MDA content and an increase in SOD and catalase 
activities; Dragon’s blood decreased hydrogen peroxide and MDA levels and increased SOD 
activity and glutathione content in carbon-irradiated rat brain [91]. These last experiments 
provide indirect proofs of the major role of oxidative stress in hadrontherapy toxicity.
3.4. Stress-induced premature senescence
In normal human fibroblasts, radiation exposure lead to a G1 cell cycle arrest evolving in 
quiescence or senescence [92]. Premature senescence, or SIPS (stress-induced premature 
senescence), differs from replicative senescence. SIPS phenomenon was generally observed in 
fibroblasts exposed to prolonged or repeated stresses [93, 94] and was also shown after X-ray 
exposure [95, 96]. Naka et al. [96] showed, by the use of ATM mutated fibroblasts, that path-
way leading to premature senescence in fibroblasts after oxidative stress or X-ray exposure 
could also be ATM-dependent and could act via p38MAPK and p16INK4A. After carbon ion 
exposure, a higher accumulation of p21 in carbon-irradiated confluent normal fibroblasts was 
observed at late times compared to X-rays [70]. In normal human lung fibroblasts, carbon ion 
irradiation led to a faster senescence than γ-rays [97] However, this phenomenon of prema-
ture senescence was observed in the same proportion as for X-rays in the progeny of human 
fibroblasts after an immediate cell cycle arrest and senescence reappeared and persisted 
after 5 months after exposure [98]. Our experiments on confluent primary cultures of normal 
human skin fibroblasts showed a lower proportion of senescence-associated β-galactosidase 
cells 3 weeks after carbon ion exposure compared to X-rays (unpublished results) (Figure 3).
3.5. Inflammation and late toxicity
Schematically, acute side effects in normal tissues would be generally related to a loss of fast 
renewal cells, whereas late effects would appear due to several more complex phenomena 
as the loss of low renewal cells, progressive ischemia due to the loss of microvascularization 
endothelial cells and the development of late fibrosis, mainly due to inflammatory processes 
[99, 100]. After irradiation, it is known that cytokines, which are important mediators of late 
radiation-induced effects, are not only secreted at early times after irradiation but also at 
later times-months or years after exposure. Normal tissues monocytes and macrophages pro-
duce proinflammatory cytokines like IL-1, IL-6 and TNF-α, which attract macrophages and 
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lymphocytes. Activated macrophages and stimulated stromal cells synthetize fibrogenic cyto-
kines such as TGF-β and PDGF modulating fibroblast proliferation-differentiation balance 
and protein synthesis and degradation via metalloproteinases (MMP) and their inhibitors 
(TIMP) (for review, [99, 101]). In this way, specificity of proton or carbon ion irradiation con-
cerning these pathways is of main interest to modulate late effects of hadrontherapy. Fournier 
et al. [102] showed an accumulation of fibrocytes and extracellular matrix proteins in normal 
human foreskin fibroblasts exposed to carbon ions. However, a lowered increase in IL-6 was 
observed in normal human skin fibroblasts exposed to carbon ion compared to X-ray irradia-
tion [3]. The use of Dragon’s blood, which presents antioxidant and anti-inflammatory prop-
erties, did not allow to reduce TNF-α, IFN-γ and IL-6 levels in carbon-irradiated rat brain as it 
was the case for γ-rays [91]. A recent report on carbon-irradiated normal human skin models 
showed similar inflammatory processes than after the same dose of X-rays [103].
3.6. Bystander effects
Bystander effect, i.e. biological effects to cells which were not irradiated via signals coming 
from irradiated cells, could be at the origin of normal surrounding tissue injury and to, for 
example, abscopal effects. Oxidative stress signal pathways could play an important role in 
these effects.
Indeed, confluent human skin fibroblasts were shown to present a persistent oxidative stress 
after exposure of 0.036–0.4% of them to proton or X-ray microbeam but this was not the case 
for carbon ions [104]. However, when normal cell cultures exposed to low-LET protons were 
co-cultured with unirradiated cells and after 20 population doublings, no changes in survival, 
chromosomal damage, protein oxidation and lipid peroxidation were observed [105]. This 
was not the case for higher LET (iron and silicon ions) for which a higher level of oxidative 
damage, a decrease in antioxidant enzyme activities and an alteration of mitochondiral pro-
teins - encoded by mitochondiral DNA - were observed [105].
Recently, Autsavapromporn et al. [106] have shown that glioblastoma cell carbon irradiation 
led to damage in unirradiated normal fibroblasts. Moreover, a single dose of carbon irradiation 
Figure 3. Premature senescence in normal human skin fibroblasts exposed to carbon ions or X-rays at an isosurvival 
dose (unpublished results). Cells were irradiated at confluence and kept until 14 or 21 days post irradiation. After 
fixation, SA-β-galactosidase staining was performed (citric acid/sodium phosphate 40 mM, NaCl 150 mM, MgCl2 2 mM, potassium ferrocyanide 5 mM, potassium ferricyanide 5 mM and X-gal 1 mg/mL). SA-β-galactosidase activity was 
determined by counting blue cells using a microscope. Data represent mean percentage of β-gal positive cells ± SEM.
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led to less damage than a fractionated dose. However, after 20 population doublings, there 
were more damage on cells irradiated in one time than in several fractions. Dose hypofraction-
ation, which is presented as a major advantage of carbon therapy, could therefore engender 
more late effects to bystander normal tissues. Inflammatory pathways playing an important 
role in oxidative stress persistence in normal tissues after irradiation thus leading to normal 
tissue injury, the study of bystander effects on the secretion of inflammatory cytokines is of 
major interest. Carbon microbeam irradiation of a low proportion (0.45%) of immune cells led 
to decreased cytokine levels [107]. Oxidized extracellular DNA could also be a signaling fac-
tor in bystander effects. 8-oxodG is the main oxidatively generated DNA lesion and is formed 
either by direct oxidation or can be incorporated in DNA from oxidized nucleotide pool by 
DNA polymerase. Its extracellular presence can be due to DNA repair, cell death, mitochon-
drial turnover, cellular uptake or salvage of DNA damage products. Carbon-irradiated conflu-
ent skin fibroblasts exhibited a 1.5-fold increase in extracellular 8-oxodG 24 hours and 2 weeks 
after C-ion beam exposure compared to X-rays (see Table 1, personal unpublished data). In 
this way, the role of bystander effects in carbon or proton therapy remains unclear and needs 
further investigations.
Cell culture supernatants were purified by solid phase extraction, and samples were adjusted 
for the standard addition method in order to correct for the matrix effects contributed by the 
culture medium constituents as reported previously [108]. An optimized method for the quan-
tification of 8-oxodG has been applied. HPLC-ECD signals were recorded in the culture super-
natants spiked with the external standard. Data represent mean 8-oxodG concentration ± SEM.
4. Conclusion
Mainly due to the cost of hadrontherapy facilities, there are too few studies dealing with 
biological effects of protons, carbon ions or other particles on tumors and normal tissues. 
In addition, a large proportion of these works did not compare carbon ion effects to X-ray 
effects. Advantages of hadrons, mostly on tumors, are often highlighted but particular atten-
tion should be paid on side effects of hadrons, especially hypofractionation which could 
lead to major injuries in normal tissues. Killing efficiency of carbon ions is often considered 
lower for normal cells than for tumor cells. However, some recent studies tend to show a 
strong increase in oxidative stress in normal cells after protons [74, 79] or carbon ions [3, 84]. 
8-oxodG concentration (nM)
Time after irradiation 24 hours 14 days
X-ray control 0.775 +/- 0.140 0.817 +/- 0.036
X-ray irradiated 1.980 +/- 0.064 2.175 +/- 0.073
C-ion control 0.822 +/- 0.103 0.830 +/- 0.084
C-ion irradiated 3.103 +/- 0.296 3.153 +/- 0.262
Table 1. 8-oxodG concentration in normal human skin fibroblast culture supernatants exposed to carbon ions or X-rays 
at an isosurvival dose (unpublished results).
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According to the literature, Figure 4 proposed a schema of biological effects leading to tumor 
cell death or to normal cell toxicity.
Further investigations are needed to better understand toxicity of protons and carbon ions. 
Prediction of side effects for each patient should be of major interest in order to adapt radio-
therapy protocol and/or to prevent deleterious effects due to normal tissue irradiation or 
to bystander phenomena. The use of antioxidants, which were demonstrated as efficient in 
reducing late effects of protons and carbon ions, could be of major interest in preserving 
normal tissue during proton or carbon ion therapy. Another guideline for reflection is related 
to the drawbacks of protons and carbon ions: they could lead to an interest of other ions as 
helium ions which should lead to less toxicity in normal tissues but are also less efficient on 
cancer cells and which do not present the same interest as carbon ions in killing tumor cells in 
hypoxic conditions. In conclusion, due to complex effects of hadrons when encountering nor-
mal tissues and tumors, there is a strong need in preclinical studies—at early and late times 
post-irradiation and in comparison to photons—to determine biological effects of SOBP, ion 
fragmentation, LET distribution in depth, hypofractionation, beam scanning, etc.
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